glutathione small cell lung cancer Decreased biosynthesis contributes to EGFR T790M-driven erlotinib resistance in non-small low glutathione and lung cancer
low glutathione and lung cancer Increased antioxidative defense reduced advanced glycation end product formation by metabolic adaptation in The crosstalk between glutathione metabolism and non coding RNAs in cancer progression and treatment resistance ScienceDirect NRF2 supports non small cell lung cancer growth independently of CBP p300 enhanced glutathione synthesis EMBO Reports Springer Nature Link Metabolic reprogramming in non small cell lung cancer: unraveling therapeutic vulnerabilities and resistance mechanisms Journal of Rare Diseases Springer Nature Link
Pay in 4 interest-free payments of $7.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17



